• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Top Stories for the Week of Oct. 22nd 2007

Top Stories for the Week of Oct. 22nd 2007

October 26, 2007
CenterWatch Staff

Top News

 
Omnicare Clinical Research Expands in India

In an effort to gear up for the company's growth in India, King of Prussia, Pa.-based contract research organization (CRO) Omnicare Clinical Research has doubled the size of its Bangalore, India, office by relocating to a 10,000-square-foot facility nearby. Omnicare Clinical Research established its first presence in India in 2002 with the opening of its original Bangalore location. The CRO’s new location will act as the company’s central hub for all operations in India. It will add staff for clinical monitoring, data management, business development and administrative. The location already has a staff of 75.

Medicare's Trial Coverage Memorandum Calls for Further Study

The Center for Medicare and Medicaid Services (CMS) will seek further comment on proposals for covering the costs of clinical trials for Medicare beneficiaries. In July 2006, the Center for Medicare and Medicaid Services (CMS) began a process of shoring up several six-year-old policy issues dealing with insuring beneficiaries participating in clinical trials. On July 9 of this year, CMS issued a draft proposal and invited public comment. But after a long summer of negotiations with stakeholders, CMS issued it Final Decision Memorandum stating it could not make new policy changes to the draft proposal.

Other breaking news...

  • OmniComm Systems inks 10 new contracts during third quarter...
  • Investors win lawsuit against ex-aaiPharma executives...

Company Profile: An interview with Igor Stefanov, director of business development, Synergy Research Group

To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing